Search

Anthony H Nguyen

Examiner (ID: 17425)

Most Active Art Unit
2854
Art Unit(s)
3307, 2854, 2853
Total Applications
2014
Issued Applications
1600
Pending Applications
48
Abandoned Applications
337

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7466201 [patent_doc_number] => 20040198682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (siNA)' [patent_app_type] => new [patent_app_number] => 10/683990 [patent_app_country] => US [patent_app_date] => 2003-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 57802 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198682.pdf [firstpage_image] =>[orig_patent_app_number] => 10683990 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/683990
RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (siNA) Oct 9, 2003 Abandoned
Array ( [id] => 7133460 [patent_doc_number] => 20040043007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Transfection system' [patent_app_type] => new [patent_app_number] => 10/296087 [patent_app_country] => US [patent_app_date] => 2003-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6868 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043007.pdf [firstpage_image] =>[orig_patent_app_number] => 10296087 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/296087
Transfection system Sep 17, 2003 Abandoned
Array ( [id] => 7530254 [patent_doc_number] => 07842476 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-30 [patent_title] => 'In vitro peptide expression library' [patent_app_type] => utility [patent_app_number] => 10/526479 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 19599 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/842/07842476.pdf [firstpage_image] =>[orig_patent_app_number] => 10526479 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/526479
In vitro peptide expression library Sep 4, 2003 Issued
Array ( [id] => 7275548 [patent_doc_number] => 20040234999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Genetic suppression and replacement' [patent_app_type] => new [patent_app_number] => 10/651754 [patent_app_country] => US [patent_app_date] => 2003-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 37654 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234999.pdf [firstpage_image] =>[orig_patent_app_number] => 10651754 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/651754
Genetic suppression and replacement Aug 28, 2003 Abandoned
Array ( [id] => 7403712 [patent_doc_number] => 20040023914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Antisense modulation of apaf-1 expression' [patent_app_type] => new [patent_app_number] => 10/399214 [patent_app_country] => US [patent_app_date] => 2003-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26122 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023914.pdf [firstpage_image] =>[orig_patent_app_number] => 10399214 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/399214
Antisense modulation of apaf-1 expression Aug 24, 2003 Abandoned
Array ( [id] => 7314209 [patent_doc_number] => 20040033967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Alkylated hexitol nucleoside analogues and oligomers thereof' [patent_app_type] => new [patent_app_number] => 10/362660 [patent_app_country] => US [patent_app_date] => 2003-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18931 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033967.pdf [firstpage_image] =>[orig_patent_app_number] => 10362660 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/362660
Alkylated hexitol nucleoside analogues and oligomers thereof Aug 17, 2003 Abandoned
Array ( [id] => 7603379 [patent_doc_number] => 07235653 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-26 [patent_title] => 'Oligonucleotide compositions and methods for the modulation of the expression of B7 protein' [patent_app_type] => utility [patent_app_number] => 10/641962 [patent_app_country] => US [patent_app_date] => 2003-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 46721 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235653.pdf [firstpage_image] =>[orig_patent_app_number] => 10641962 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/641962
Oligonucleotide compositions and methods for the modulation of the expression of B7 protein Aug 14, 2003 Issued
Array ( [id] => 7033559 [patent_doc_number] => 20050032068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Sugar and backbone-surrogate-containing oligomeric compounds and compositions for use in gene modulation' [patent_app_type] => utility [patent_app_number] => 10/634483 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34396 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032068.pdf [firstpage_image] =>[orig_patent_app_number] => 10634483 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/634483
Sugar and backbone-surrogate-containing oligomeric compounds and compositions for use in gene modulation Aug 4, 2003 Abandoned
Array ( [id] => 7033558 [patent_doc_number] => 20050032067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Non-phosphorous-linked oligomeric compounds and their use in gene modulation' [patent_app_type] => utility [patent_app_number] => 10/634320 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32277 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032067.pdf [firstpage_image] =>[orig_patent_app_number] => 10634320 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/634320
Non-phosphorous-linked oligomeric compounds and their use in gene modulation Aug 4, 2003 Abandoned
Array ( [id] => 7394398 [patent_doc_number] => 20040038392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Expression vector enabling screening of cells with high expression of recombinant protein, transformant with high expression of recombinant protein and utilization thereof' [patent_app_type] => new [patent_app_number] => 10/297473 [patent_app_country] => US [patent_app_date] => 2003-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13855 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038392.pdf [firstpage_image] =>[orig_patent_app_number] => 10297473 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/297473
Expression vector enabling screening of cells with high expression of recombinant protein, transformant with high expression of recombinant protein and utilization thereof Jul 20, 2003 Abandoned
Array ( [id] => 5771606 [patent_doc_number] => 20050267057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Immunostimulatory nucleic acid molecules' [patent_app_type] => utility [patent_app_number] => 10/619279 [patent_app_country] => US [patent_app_date] => 2003-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 27142 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20050267057.pdf [firstpage_image] =>[orig_patent_app_number] => 10619279 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/619279
Immunostimulatory nucleic acid molecules Jul 13, 2003 Issued
Array ( [id] => 5875923 [patent_doc_number] => 20060167227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Truncated tau proteins' [patent_app_type] => utility [patent_app_number] => 10/521140 [patent_app_country] => US [patent_app_date] => 2003-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 23515 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167227.pdf [firstpage_image] =>[orig_patent_app_number] => 10521140 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/521140
Truncated tau proteins Jul 8, 2003 Abandoned
Array ( [id] => 7460674 [patent_doc_number] => 20040052840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Preparations for oligonucleotide transfer' [patent_app_type] => new [patent_app_number] => 10/311621 [patent_app_country] => US [patent_app_date] => 2003-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13918 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20040052840.pdf [firstpage_image] =>[orig_patent_app_number] => 10311621 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/311621
Preparations for oligonucleotide transfer Jun 22, 2003 Abandoned
Array ( [id] => 7475830 [patent_doc_number] => 20040097990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Graft material, device & method of making' [patent_app_type] => new [patent_app_number] => 10/600364 [patent_app_country] => US [patent_app_date] => 2003-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3257 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097990.pdf [firstpage_image] =>[orig_patent_app_number] => 10600364 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/600364
Graft material, device & method of making Jun 20, 2003 Abandoned
Array ( [id] => 7393367 [patent_doc_number] => 20040038274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Gapped 2\' modified oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/601242 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13992 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038274.pdf [firstpage_image] =>[orig_patent_app_number] => 10601242 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/601242
Gapped 2' modified oligonucleotides Jun 19, 2003 Abandoned
Array ( [id] => 7674678 [patent_doc_number] => 20040127440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Methods and compositions for control of bone formation via modulation of neuropeptide Y activity' [patent_app_type] => new [patent_app_number] => 10/465910 [patent_app_country] => US [patent_app_date] => 2003-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 32001 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127440.pdf [firstpage_image] =>[orig_patent_app_number] => 10465910 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/465910
Methods and compositions for control of bone formation via modulation of neuropeptide Y activity Jun 16, 2003 Abandoned
Array ( [id] => 7469137 [patent_doc_number] => 20040102406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Antisense oligonucleotides to inhibit angiogenesis and/or metastasis' [patent_app_type] => new [patent_app_number] => 10/312752 [patent_app_country] => US [patent_app_date] => 2003-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8033 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102406.pdf [firstpage_image] =>[orig_patent_app_number] => 10312752 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/312752
Antisense oligonucleotides to inhibit angiogenesis and/or metastasis Jun 11, 2003 Abandoned
Array ( [id] => 7224759 [patent_doc_number] => 20040072783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Nucleozymes with endonuclease activity' [patent_app_type] => new [patent_app_number] => 10/457039 [patent_app_country] => US [patent_app_date] => 2003-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15748 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072783.pdf [firstpage_image] =>[orig_patent_app_number] => 10457039 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/457039
Nucleozymes with endonuclease activity Jun 5, 2003 Abandoned
Array ( [id] => 7357957 [patent_doc_number] => 20040014055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Gene coding for erbin, and diagnostic and therapeutic uses thereof' [patent_app_type] => new [patent_app_number] => 10/240926 [patent_app_country] => US [patent_app_date] => 2003-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10764 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014055.pdf [firstpage_image] =>[orig_patent_app_number] => 10240926 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/240926
Gene coding for erbin, and diagnostic and therapeutic uses thereof Jun 4, 2003 Abandoned
Array ( [id] => 6635366 [patent_doc_number] => 20030211611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Antisense modulation of estrogen receptor alpha expression' [patent_app_type] => new [patent_app_number] => 10/448753 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27671 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211611.pdf [firstpage_image] =>[orig_patent_app_number] => 10448753 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/448753
Antisense modulation of estrogen receptor alpha expression May 29, 2003 Abandoned
Menu